Search images on Google Product Monograph
Active Ingredients:
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a, 60 MCG/0.5 ML
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b, 60 MCG/0.5 ML
DIN: 02468751
Dosage Form(s): SUSPENSION
Route(s) of Administration: INTRAMUSCULAR
Description: BIVALENT RECOMBINANT LIPOPROTEIN (RLP2086) - PREFILLED SYRINGE
Schedule: Schedule D
Company: PFIZER CANADA ULC
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07A - BACTERIAL VACCINES (ATC, WHO)
- J07AH - Meningococcal vaccines (ATC, WHO)
- J07AH - MENINGOCOCCAL VACCINES (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1/10 SYR
External Links for Trumenba:
Search on Google
- Trumenba side effects
- Trumenba dosage
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a side effects
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a dosage
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b side effects
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b dosage